U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06805266) titled 'Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson Disease' on Jan. 16.
Brief Summary: The present study involves patients with Parkinson Disease (PD) suffering from freezing of gait (FOG) and depressive symptoms. The main aim of the study is evaluating the efficacy of vortioxetine in reducing moderate/severe FOG not responsive to dopaminergic treatment in patients with PD with depressive symptoms.
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
Parkinson Disease, Idiopathic
Freezing of Gait
Depression Not Otherwise Specified
Intervention:
DRUG: Vortioxetine (tablet)
Vortioxetine will be ...